G. Michael Felker

46.7k total citations · 12 hit papers
417 papers, 24.0k citations indexed

About

G. Michael Felker is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, G. Michael Felker has authored 417 papers receiving a total of 24.0k indexed citations (citations by other indexed papers that have themselves been cited), including 337 papers in Cardiology and Cardiovascular Medicine, 83 papers in Pulmonary and Respiratory Medicine and 53 papers in Surgery. Recurrent topics in G. Michael Felker's work include Heart Failure Treatment and Management (264 papers), Cardiovascular Function and Risk Factors (132 papers) and Cardiac pacing and defibrillation studies (65 papers). G. Michael Felker is often cited by papers focused on Heart Failure Treatment and Management (264 papers), Cardiovascular Function and Risk Factors (132 papers) and Cardiac pacing and defibrillation studies (65 papers). G. Michael Felker collaborates with scholars based in United States, Canada and Italy. G. Michael Felker's co-authors include Christopher M. O’Connor, Adrian F. Hernandez, Linda K. Shaw, Kirkwood F. Adams, Christopher M. O'Connor, Edward K. Kasper, Robert J. Mentz, Joshua M. Hare, Marco Metra and Adriaan A. Voors and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

G. Michael Felker

403 papers receiving 23.4k citations

Hit Papers

Underlying Causes and Long-Term Survival in Patients with... 2000 2026 2008 2017 2000 2007 2012 2016 2019 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
    2000 1.2k citations G. Michael Felker et al. profile →
  2. Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure
    2007 752 citations G. Michael Felker, Larry A. Allen et al. Journal of the American College of Cardiology profile →
  3. Decision Making in Advanced Heart Failure
    2012 554 citations Larry A. Allen, G. Michael Felker et al. Circulation profile →
  4. Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
    2016 475 citations Kenneth B. Margulies, Adrian F. Hernandez et al. profile →
  5. Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction
    2019 413 citations James L. Januzzi, Margaret F. Prescott et al. profile →
  6. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association
    2017 404 citations Sheryl L. Chow, Alan S. Maisel et al. Circulation profile →
  7. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
    2015 370 citations Kevin J. Anstrom, Horng H. Chen et al. profile →
  8. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial
    2016 337 citations Barry Greenberg, Javed Butler et al. profile →
  9. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency
    2017 323 citations Adrian F. Hernandez, G. Michael Felker et al. profile →
  10. Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction
    2017 321 citations G. Michael Felker, Kevin J. Anstrom et al. profile →
  11. Diuretic Therapy for Patients With Heart Failure
    2020 223 citations G. Michael Felker et al. Journal of the American College of Cardiology profile →
  12. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury
    2018 208 citations Tariq Ahmad, W.H. Wilson Tang et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Michael Felker United States 83 17.3k 4.3k 4.2k 2.5k 2.4k 417 24.0k
Marco Metra Italy 88 23.9k 1.4× 4.1k 1.0× 5.7k 1.3× 3.0k 1.2× 2.5k 1.0× 808 32.4k
Marvin A. Konstam United States 72 21.7k 1.3× 4.5k 1.1× 5.6k 1.3× 2.5k 1.0× 2.5k 1.0× 321 29.1k
Biykem Bozkurt United States 66 19.4k 1.1× 6.9k 1.6× 5.2k 1.2× 2.3k 0.9× 1.9k 0.8× 251 27.7k
Mariell Jessup United States 59 19.3k 1.1× 5.6k 1.3× 3.0k 0.7× 2.6k 1.0× 4.0k 1.7× 194 25.6k
James L. Januzzi United States 100 27.1k 1.6× 6.7k 1.6× 6.6k 1.6× 3.4k 1.4× 1.8k 0.7× 745 39.4k
Richard J. Rodeheffer United States 68 18.1k 1.0× 3.7k 0.9× 3.0k 0.7× 2.2k 0.9× 1.6k 0.6× 198 23.8k
Mihai Gheorghiade United States 93 18.7k 1.1× 3.9k 0.9× 6.0k 1.4× 3.5k 1.4× 2.1k 0.9× 411 26.1k
Frank Ruschitzka Switzerland 61 14.8k 0.9× 3.8k 0.9× 2.7k 0.6× 1.9k 0.8× 1.3k 0.5× 384 21.4k
Lars H. Lund Sweden 71 15.0k 0.9× 8.5k 2.0× 3.7k 0.9× 1.9k 0.8× 4.1k 1.7× 433 25.1k
Wilbert S. Aronow United States 66 13.7k 0.8× 5.2k 1.2× 3.3k 0.8× 1.6k 0.6× 1.2k 0.5× 1.2k 22.2k

Countries citing papers authored by G. Michael Felker

Since Specialization
Citations

This map shows the geographic impact of G. Michael Felker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Michael Felker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Michael Felker more than expected).

Fields of papers citing papers by G. Michael Felker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Michael Felker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Michael Felker. The network helps show where G. Michael Felker may publish in the future.

Co-authorship network of co-authors of G. Michael Felker

This figure shows the co-authorship network connecting the top 25 collaborators of G. Michael Felker. A scholar is included among the top collaborators of G. Michael Felker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Michael Felker. G. Michael Felker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harrington, Josephine, Anna Giczewska, Vishal N. Rao, et al.. (2025). Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index. JACC Heart Failure. 14(3). 102768–102768. 1 indexed citations
2.
Cunningham, Jonathan W., William T. Abraham, Ankeet S. Bhatt, et al.. (2024). Artificial Intelligence in Cardiovascular Clinical Trials. Journal of the American College of Cardiology. 84(20). 2051–2062. 11 indexed citations
3.
Biegus, Jan, JoAnn Lindenfeld, G. Michael Felker, et al.. (2024). Design and Rationale of the eLym™ System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA-HF). ESC Heart Failure. 12(3). 1719–1726. 3 indexed citations
4.
Harrington, Josephine, Gregg C. Fonarow, Muhammad Shahzeb Khan, et al.. (2023). Medication-Attributable Adverse Events in Heart Failure Trials. JACC Heart Failure. 11(4). 425–436. 11 indexed citations
5.
Lala, Anuradha, Carine Hamo, Biykem Bozkurt, et al.. (2023). Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies. JACC Heart Failure. 12(1). 1–15. 11 indexed citations
6.
Rao, Vishal N., Anna Giczewska, Karen Chiswell, et al.. (2023). Long-term outcomes of phenoclusters in severe tricuspid regurgitation. European Heart Journal. 44(21). 1910–1923. 20 indexed citations
7.
Harrington, Josephine, G. Michael Felker, Ildiko Lingvay, et al.. (2023). Managing Obesity in Heart Failure. JACC Heart Failure. 12(1). 28–34. 4 indexed citations
8.
Randhawa, Varinder K., João Pedro Ferreira, James M. Brophy, et al.. (2022). Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta‐Analysis. Journal of the American Heart Association. 11(10). e024833–e024833. 14 indexed citations
9.
Granger, Bradi B., Lisa A. Kaltenbach, Gregg C. Fonarow, et al.. (2022). Health System–Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial. Journal of Cardiac Failure. 28(8). 1355–1361. 6 indexed citations
10.
Emmens, Johanna E., Jozine M. ter Maaten, Yuya Matsue, et al.. (2021). Worsening renal function in acute heart failure in the context of diuretic response. European Journal of Heart Failure. 24(2). 365–374. 41 indexed citations
11.
Fudim, Marat, Anna Giczewska, Stephen J. Greene, et al.. (2020). Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS‐HF. Journal of the American Heart Association. 9(24). e015752–e015752. 14 indexed citations
12.
Sharma, Abhinav, Xin Zhao, Bradley G. Hammill, et al.. (2018). Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure. Circulation Heart Failure. 11(6). e004646–e004646. 129 indexed citations
13.
Grodin, Justin L., Javed Butler, Marco Metra, et al.. (2018). Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial. Journal of Cardiac Failure. 24(8). 512–519. 7 indexed citations
14.
Chow, Sheryl L., Alan S. Maisel, Inder S. Anand, et al.. (2017). Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 135(22). e1054–e1091. 404 indexed citations breakdown →
15.
Grodin, Justin L., Susanna R. Stevens, Lisa de las Fuentes, et al.. (2015). Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure. Journal of Cardiac Failure. 22(1). 26–32. 41 indexed citations
16.
Cotter, Gad, Adriaan A. Voors, Margaret F. Prescott, et al.. (2015). Growth Differentiation Factor 15 (GDF-15) in Patients Admitted for Acute Heart Failure: Results from the RELAX-AHF Study. European Journal of Heart Failure. 17(11). 1133–1143. 88 indexed citations
17.
Fiuzat, Mona, Phillip J. Schulte, G. Michael Felker, et al.. (2013). Relationship Between Galectin-3 Levels and Mineralocorticoid Receptor Antagonist Use in Heart Failure: Analysis From HF-ACTION. Journal of Cardiac Failure. 20(1). 38–44. 24 indexed citations
18.
Mentz, Robert J., Adrian F. Hernandez, Amanda Stebbins, et al.. (2012). Predictors of Early Dyspnoea Relief in Acute Heart Failure and the Association with 30-Day Outcomes: Findings from ASCEND-HF. European Journal of Heart Failure. 15(4). 456–464. 34 indexed citations
19.
Voors, Adriaan A., Beth A. Davison, G. Michael Felker, et al.. (2011). Early Drop in Systolic Blood Pressure and Worsening Renal Function in Acute Heart Failure: Renal Results of Pre-RELAX-AHF. European Journal of Heart Failure. 13(9). 961–967. 90 indexed citations
20.
Milo‐Cotter, Olga, Kirkwood F. Adams, Christopher M. O’Connor, et al.. (2006). Acute Heart Failure Associated with High Admission Blood Pressure — A Distinct Vascular Disorder?. European Journal of Heart Failure. 9(2). 178–183. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Metra Breakdown of academic impact, for papers by Marvin A. Konstam Breakdown of academic impact, for papers by Biykem Bozkurt Breakdown of academic impact, for papers by Mariell Jessup Breakdown of academic impact, for papers by James L. Januzzi Breakdown of academic impact, for papers by Richard J. Rodeheffer Breakdown of academic impact, for papers by Mihai Gheorghiade Breakdown of academic impact, for papers by Frank Ruschitzka Breakdown of academic impact, for papers by Lars H. Lund Breakdown of academic impact, for papers by Wilbert S. Aronow
Rankless by CCL
2026